DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $875,048 | +7.9% | 3,527 | +4.4% | 0.29% | +7.4% |
| Q2 2023 | $810,720 | -5.7% | 3,378 | -0.9% | 0.27% | -11.7% |
| Q1 2023 | $859,454 | -11.2% | 3,410 | -6.5% | 0.31% | -23.1% |
| Q4 2022 | $967,722 | +3.9% | 3,646 | +1.2% | 0.40% | -2.2% |
| Q3 2022 | $931,000 | +4.7% | 3,601 | +2.7% | 0.41% | +12.1% |
| Q2 2022 | $889,000 | -8.6% | 3,507 | +5.7% | 0.36% | +14.5% |
| Q1 2022 | $973,000 | -11.3% | 3,318 | -0.5% | 0.32% | +2.3% |
| Q4 2021 | $1,097,000 | +7.9% | 3,335 | -0.1% | 0.31% | +5.4% |
| Q3 2021 | $1,017,000 | +13.8% | 3,338 | +0.2% | 0.30% | +15.7% |
| Q2 2021 | $894,000 | +21.3% | 3,330 | +1.8% | 0.26% | +10.4% |
| Q1 2021 | $737,000 | +2.1% | 3,271 | +0.6% | 0.23% | -0.4% |
| Q4 2020 | $722,000 | -55.4% | 3,250 | -56.8% | 0.23% | -53.0% |
| Q3 2020 | $1,618,000 | +105.3% | 7,521 | +68.5% | 0.49% | +54.9% |
| Q2 2020 | $788,000 | +30.5% | 4,463 | +2.3% | 0.32% | +6.0% |
| Q1 2020 | $604,000 | -19.8% | 4,362 | -11.2% | 0.30% | +3.4% |
| Q4 2019 | $753,000 | – | 4,912 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |